Brief: Natco Pharma Dec-Quarter Consol Net Profit 1.52 Billion Rupees
12/02/2026 09:05
Feb 12 (Reuters) - Natco Pharma Ltd NATP.NS: DEC-QUARTER CONSOL NET PROFIT 1.52 BILLION RUPEES DEC-QUARTER CONSOL REVENUE FROM OPERATIONS 6.47 BILLION RUPEES RE-APPOINTMENT OF RAJEEV NANNAPANENI AS CEO DECLARED DIVIDEND OF RS. 1.50 RUPEES PER SHARE RE-APPOINTMENT OF VENKAIAH CHOWDARY NANNAPANENI AS CHAIRMAN & MANAGING DIRECTOR Further company coverage: NATP.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Natco Pharma
See all newsBrief: Natco Pharma March-Quarter Consol Net Profit 2.68 Billion Rupees
Brief: Natco Pharma Gets Demand Of 49.2 Million Rupees From National Pharmaceutical Pricing Authority
Brief: Natco Pharma To Incorporate Wholly Owned Subsidiary In Nigeria With Investment Up To $100,000
Factbox: Indian drugmakers flood market with cheaper versions of Novo's Ozempic, Wegovy
Analysts upbeat on semaglutide opportunity as patent expiry triggers India generics